Another exciting area of personalized medicine is using nanotechnology for gene therapy. Gene therapy involves altering or ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The Moderna and Pfizer agreements include options for a total of 600 million doses, 300 million apiece, but these can only be exercised with additional funding from Congress, according to HHS.

Today, Moderna sells just two products: its Covid vaccine called Spikevax — a rival to Comirnaty from Pfizer and BioNTech, ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine. The company projects optimism in its long-term outlook, believing that several pending product approvals can ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...